T1	Gene 14541 14547	hyl1-2
T2	Phenotype 14559 14645	decreased antisense transcript expression by 20-50% for APS1, MYB12, SCL6(IV) and TOE2
R1	Causation Arg1:T1 Arg2:T2	
T3	Gene 14783 14789	hyl1-2
T4	Phenotype 14688 14779	ARF17/AT1G77850 and MET2/AT4G14140 antisense transcript expression levels were up-regulated
R2	Causation Arg1:T3 Arg2:T4	
T5	Gene 16933 16940	rdr6-15
T6	Phenotype 16949 17031	MYB12, SCL6(IV), TOE2, and TCP4 antisense transcript expression was down-regulated
T7	Phenotype 17052 17101	increase of UBC24/AT2G33770 antisense transcripts
R3	Causation Arg1:T5 Arg2:T6	
R4	Causation Arg1:T5 Arg2:T7	
T8	Gene 16609 16616	sgs3-14
T9	Phenotype 16625 16715	APS1, MYB12, TOE2, DCL1, SPL10, and TCP4 had increased expression of antisense transcripts
R5	Causation Arg1:T8 Arg2:T9	
T10	Gene 14074 14080	hen1-1
T11	Phenotype 13940 14070	APS1/AT3G22890, MYB12/AT2G47460, AP2/AT4G36920, and GRF8/AT4G24150 antisense transcript signals which demonstrate 20-40% increases
R6	Causation Arg1:T10 Arg2:T11	
T12	Gene 19660 19666	hen1-1
T13	Gene 19671 19678	sgs3-14
T14	Phenotype 19607 19656	elevated expression of DCL1 antisense transcripts
R7	Causation Arg1:T12 Arg2:T14	
R8	Causation Arg1:T13 Arg2:T14	
T15	Gene 19892 19898	hyl1-2
T16	Phenotype 19840 19884	antisense transcripts of MET2 were increased
R9	Causation Arg1:T15 Arg2:T16	
T17	Gene 20388 20394	hen1-1
T18	Phenotype 20404 20506	most antisense transcripts of validated miRNA targets were elevated along with their sense transcripts
R10	Causation Arg1:T17 Arg2:T18	
